fda warning bpc 157 compounded peptide not approved Most people hear “not approved” and immediately think unsafe or ineffective… but the reality is a lot more about economics than science. If something can't be patented, there's little incentive to FDA mulls compounding for peptides
Description
It also acts as a lipotropic which converts fats into other useful products
Saeedi, P
If you're transitioning from GHK-Cu research, consider starting with conservative AHK-Cu doses and meticulously observe the responses
He and colleagues published their results November 24 in Scientific Reports
